Search

Embecta Corp

Open

SectorHealthcare

6.17 -0.64

Overview

Share price change

24h

Current

Min

5.9

Max

6.23

Key metrics

By Trading Economics

Income

25M

21M

Sales

50M

272M

P/E

Sector Avg

4.065

48.735

EPS

0.56

Dividend yield

7.68

Profit margin

7.766

Employees

1,850

EBITDA

20M

65M

Dividends

By Acuity

Dividend yield

Sector Avg

7.68%

2.24%

Next Earnings

24 Nov 2026

Next Dividend date

17 Dec 2026

Next Ex Dividend date

4 Dec 2026

Market Stats

By TradingEconomics

Market Cap

118M

339M

Previous open

6.81

Previous close

6.17

Embecta Corp Chart

Past performance is not a reliable indicator of future results.

Related News

13 Oct 2026, 20:13 UTC

Embecta Corp's shares declined during after-market hours on Tuesday, maintaining a loss since the regular session close.

12 Oct 2026, 23:06 UTC

Embecta Corp's shares advanced modestly higher in after-market trading, recovering from a low point earlier in the session while remaining above its 20-day moving average.

9 Oct 2026, 19:35 UTC

Embecta Corp's shares are roughly flat, showing little change since Thursday's close, while positioned above its 20-day moving average.

8 Oct 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, regarding potential corporate wrongdoing involving its officers and directors.

7 Oct 2026, 20:08 UTC

Embecta Corp shares fell modestly, retracing from a peak earlier in the day, but remain above their 20-day moving average.

6 Oct 2026, 19:20 UTC

Embecta Corp is trading higher, supported by broader market gains and positive economic indicators, despite earlier pulling back from a session high.

5 Oct 2026, 22:31 UTC

Embecta Corp is experiencing downward pressure in after-market trading, with losses accelerating since Monday's close while remaining above its 20-day moving average.

2 Oct 2026, 23:20 UTC

Embecta Corp is seeing a notable decline in after-market trading, reaching its lowest cumulative return since Friday's close.

1 Oct 2026, 20:07 UTC

Embecta Corp is advancing, remaining well above its previous close and significantly above its 20-day moving average, despite a slight pullback earlier in the session.

30 Sept 2026, 20:02 UTC

Embecta Corp shares fell sharply after an early high, continuing a decline since Tuesday's close while remaining above the 20-day moving average.

29 Sept 2026, 20:07 UTC

News

Embecta Corp shares are declining as Bronstein, Gewirtz & Grossman, LLC announced an investigation into potential corporate wrongdoing by the company's officers and directors.

28 Sept 2026, 20:12 UTC

Embecta Corp is trading lower in after-market hours, continuing a decline since Monday, though it remains above its 20-day moving average.

25 Sept 2026, 20:01 UTC

Embecta Corp is sharply higher, reaching a notable high and trading above its 20-day moving average, continuing an upward trend since Thursday's close.

24 Sept 2026, 20:07 UTC

Embecta Corp's shares advanced modestly, remaining above the 20-day moving average and near the upper end of their one-month trading range.

22 Sept 2026, 20:02 UTC

Embecta Corp is trading sharply higher, reaching a peak earlier in the session and remaining above its 20-day moving average.

21 Sept 2026, 21:21 UTC

Embecta Corp is declining in after-market trading, reflecting a significant dip since Monday's close and currently positioned in the middle of its one-month trading range.

18 Sept 2026, 20:04 UTC

Embecta Corp is trading higher, continuing its rise from Thursday and maintaining momentum above its 20-day moving average with three consecutive higher daily finishes.

16 Sept 2026, 20:10 UTC

Embecta Corp is advancing amid a positive market environment, though it remains below its 20-day moving average and near the lower end of its one-month range.

15 Sept 2026, 20:07 UTC

News

Embecta Corp is under investigation by Bronstein, Gewirtz & Grossman, LLC, contributing to a decline in shares amid broader market pressures.

14 Sept 2026, 20:04 UTC

Embecta Corp shares are higher today, rebounding from an early dip without specific news to explain the movement. Broader market concerns include rising crude oil prices.

11 Sept 2026, 19:16 UTC

Embecta Corp shares are higher amid U.S. Consumer Price Index data, which showed inflation at 3.4% annually, aligning with forecasts.

10 Sept 2026, 21:31 UTC

Embecta Corp shares are higher in after-market trading, continuing an upward move since Thursday's close, despite being below its 20-day moving average.

9 Sept 2026, 20:02 UTC

Embecta Corp shares are lower today, continuing a decline since Tuesday's close. The stock peaked earlier in the session before reversing sharply.

8 Sept 2026, 20:02 UTC

News

Embecta Corp shares are lower as an investigation raises governance concerns among shareholders. Investors are assessing potential implications of the inquiry.

3 Sept 2026, 19:36 UTC

Embecta Corp shares are higher as market sentiment improves amid easing interest rate concerns and declining Treasury yields.

2 Sept 2026, 23:36 UTC

Embecta Corp. shares are higher in after-market hours, reflecting broader market trends amid ADP's report of weak private sector job growth in August.

1 Sept 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified to explain the decline amid broader market concerns over rising crude oil prices.

31 Aug 2026, 20:07 UTC

Embecta Corp shares are higher today, trading near the upper end of their one-month range and above the 20-day moving average.

28 Aug 2026, 21:02 UTC

Embecta Corp shares are lower in after-market hours, with no specific news identified. The stock has shown strong performance over the past month.

27 Aug 2026, 20:07 UTC

Event
News

Bronstein, Gewirtz & Grossman, LLC is investigating Embecta Corp for potential corporate wrongdoing. Shares are trading roughly flat following the company's recent $0.01 dividend.

Peer Comparison

Price change

Embecta Corp Forecast

Rating Consensus

By TipRanks

Sell

2 ratings

0

Buy

1

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Embecta Corp

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
help-icon Live chat